Company Valuation: SaintMed

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025
Market Cap 1 3,039 1,921 1,544 955.4 494.3
Change - -36.78% -19.64% -38.11% -48.26%
Enterprise Value (EV) 1 2,825 1,429 1,255 988.6 774.7
Change - -49.43% -12.16% -21.23% -21.63%
P/E 8.4x 6.48x 20.3x 23x 46.6x
PBR 3.38x 1.87x 1.72x 1.26x 0.69x
PEG 0x -0.4x -0.3x -0.5x -0.6x
Capitalization / Revenue 1.87x 0.96x 1.87x 1.2x 0.54x
EV / Revenue 1.74x 0.71x 1.52x 1.25x 0.85x
EV / EBITDA 6.49x 3.59x 11.1x 11.8x 10.9x
EV / EBIT 6.83x 3.82x 13.9x 17.3x 20.7x
EV / FCF 39.9x 3.52x 196x -9.06x -7.26x
FCF Yield 2.51% 28.4% 0.51% -11% -13.8%
Dividend per Share 2 0.4762 0.75 0.3 0.75 0.06
Rate of return 3.52% 8.77% 4.17% 16.3% 2.52%
EPS 2 1.61 1.32 0.3539 0.2 0.0511
Distribution rate 29.6% 56.8% 84.8% 375% 117%
Net sales 1 1,621 2,010 827.3 793.2 910.2
EBITDA 1 435.5 397.5 113.3 83.68 71.05
EBIT 1 413.8 373.8 90.01 57.02 37.35
Net income 1 319.8 296.7 79.24 41.68 10.62
Net Debt 1 -213.3 -492.2 -288.8 33.12 280.4
Reference price 2 13.524 8.550 7.200 4.600 2.380
Nbr of stocks (in thousands) 224,700 224,684 214,423 207,703 207,703
Announcement Date 2/28/22 A 2/27/23 A 2/29/24 A 2/28/25 A 3/3/26 A
1THB in Million2THB
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
34.6x4.09x15.38x2.48% 181B
24.27x4.74x16.63x1.15% 120B
20.89x3.59x12.86x2.92% 119B
31.27x3.02x12.17x2.28% 91.44B
18.13x0.21x13.12x0.72% 63.07B
31.81x7.93x20.4x1.24% 55.8B
39.34x3.62x12.34x2.11% 54.03B
39.01x9.68x27.09x-.--% 45.38B
44.15x3.33x12.39x0.52% 34.37B
Average 31.49x 4.47x 15.82x 1.49% 84.83B
Weighted average by Cap. 29.91x 4.21x 15.32x 1.82%

Y-o-Y evolution of P/E

Valuation ratios - P/E - SaintMed

Historical PBR trend

Valuation ratios - PBR - SaintMed

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - SaintMed

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - SaintMed